Successful Transition from High-Dose Methadone to Buprenorphine via Microdosing in the Outpatient Setting: A Case Report.
作者信息
Jafari Siavash, Rafizadeh Reza
机构信息
, MD, MHSc, FRCPC, DABAM, is Clinical Assistant Professor in the Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, and Associate Chief Medical Information Officer for BC Mental Health and Substance Use Services, Burnaby, British Columbia.
, BSPharm, RPh, ACPR, BCPP, is a Clinical Pharmacy Specialist with the Burnaby Centre for Mental Health & Addiction, Lower Mainland Pharmacy Services, Burnaby, British Columbia, and a Clinical Instructor with the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
出版信息
Can J Hosp Pharm. 2021 Winter;74(1):83-85. Epub 2021 Jan 1.
Abstract
摘要
相似文献
1
Successful Transition from High-Dose Methadone to Buprenorphine via Microdosing in the Outpatient Setting: A Case Report.门诊环境中通过微剂量给药成功从高剂量美沙酮过渡到丁丙诺啡：一例报告
Can J Hosp Pharm. 2021 Winter;74(1):83-85. Epub 2021 Jan 1.
2
Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.使用微量剂量方案，在不进行阿片类药物戒断期的情况下，将患有阿片类药物使用障碍的住院患者从美沙酮转为丁丙诺啡。
Pharmacotherapy. 2019 Oct;39(10):1023-1029. doi: 10.1002/phar.2313. Epub 2019 Aug 15.
3
Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".门诊环境中从美沙酮快速诱导舌下丁丙诺啡：“病例系列”。
J Opioid Manag. 2021;17(7):167-170. doi: 10.5055/jom.2021.0654.
4
Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.在羁押环境中，有阿片类药物使用障碍的患者从美沙酮转为皮下丁丙诺啡植入剂-病例系列。
Am J Drug Alcohol Abuse. 2021 Sep 3;47(5):599-604. doi: 10.1080/00952990.2021.1963757. Epub 2021 Aug 18.
5
Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol with Case Examples.从美沙酮微诱导丁丙诺啡用于慢性疼痛：门诊方案及病例示例
J Pain Palliat Care Pharmacother. 2022 Mar;36(1):40-48. doi: 10.1080/15360288.2022.2049422. Epub 2022 Mar 15.
6
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.美沙酮快速转换丁丙诺啡，应用纳曲酮诱导戒断：病例报告。
Subst Abus. 2019;40(2):140-145. doi: 10.1080/08897077.2019.1573776. Epub 2019 Mar 19.
7
Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study.在住院环境中使用短效激动剂桥从美沙酮过渡到丁丙诺啡：案例研究。
J Addict Med. 2020 Sep/Oct;14(5):e274-e276. doi: 10.1097/ADM.0000000000000623.
8
Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.门诊环境中应用舌下丁丙诺啡/纳洛酮快速微诱导技术治疗阿片类药物使用障碍：病例报告。
J Addict Dis. 2022 Jul-Sep;40(3):439-443. doi: 10.1080/10550887.2021.1996153. Epub 2022 Jan 24.
9
Buprenorphine Microdosing for the Pain and Palliative Care Clinician.丁丙诺啡微剂量用于疼痛和姑息治疗临床医生。
J Palliat Med. 2022 Jan;25(1):145-154. doi: 10.1089/jpm.2021.0378.
10
Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.孕期阿片类物质使用障碍管理中从美沙酮维持治疗转换为丁丙诺啡维持治疗
Am J Drug Alcohol Abuse. 2018;44(3):310-316. doi: 10.1080/00952990.2017.1363218. Epub 2017 Aug 22.
引用本文的文献
1
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.阿片类物质使用障碍和疼痛管理中丁丙诺啡的起始策略：系统评价。
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
2
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report.使用高剂量美沙酮的患者中丁丙诺啡-纳洛酮的微剂量诱导：一例报告。
Ment Health Clin. 2021 Nov 8;11(6):369-372. doi: 10.9740/mhc.2021.11.369. eCollection 2021 Nov.
本文引用的文献
1
Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.使用微量剂量方案，在不进行阿片类药物戒断期的情况下，将患有阿片类药物使用障碍的住院患者从美沙酮转为丁丙诺啡。
Pharmacotherapy. 2019 Oct;39(10):1023-1029. doi: 10.1002/phar.2313. Epub 2019 Aug 15.
2
Management of opioid use disorders: a national clinical practice guideline.阿片类物质使用障碍的管理：一项国家临床实践指南。
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
3
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method.在重叠使用全效阿片类激动剂的情况下，使用微剂量诱导丁丙诺啡治疗：伯尔尼方法。
Subst Abuse Rehabil. 2016 Jul 20;7:99-105. doi: 10.2147/SAR.S109919. eCollection 2016.
4
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.丁丙诺啡维持治疗与安慰剂或美沙酮维持治疗用于阿片类物质依赖的比较
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD002207. doi: 10.1002/14651858.CD002207.pub4.
5
(R)-methadone versus racemic methadone: what is best for patient care?（R）-美沙酮与外消旋美沙酮：哪一种更适合患者治疗？
Addiction. 2011 Apr;106(4):687-8. doi: 10.1111/j.1360-0443.2011.03374.x.
6
Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.美沙酮和丁丙诺啡治疗期间校正QT间期延长的患病率及临床相关性：一项死亡率评估研究。
Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9.
7
QTc interval screening in methadone treatment.美沙酮治疗中的QTc间期筛查
Ann Intern Med. 2009 Mar 17;150(6):387-95. doi: 10.7326/0003-4819-150-6-200903170-00103. Epub 2009 Jan 19.
8
Practical considerations for the clinical use of buprenorphine.丁丙诺啡临床应用的实际考量
Sci Pract Perspect. 2004 Aug;2(2):4-20. doi: 10.1151/spp04224.
Zotero 插件